Clinical Trial Update: Use of Zolpidem in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating Zolpidem for Parkinson's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Zolpidem (zolpidem)

Snippet

Sponsor: Rush University Medical Center | Conditions: Parkinson's Disease | Phase 2 | Status: WITHDRAWN